An investigator-initiated clinical study of Telomelysin-radiation combination therapy for esophageal cancer

Trial Profile

An investigator-initiated clinical study of Telomelysin-radiation combination therapy for esophageal cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Telomelysin (Primary)
  • Indications Oesophageal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jul 2017 According to an Oncolys Biopharma media release, interim results from this trial will be presented at the 15th Annual Meeting of the Japanese Society of Medical Oncology (JSMO2017).
    • 17 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top